IRIS UniCatt

Tursi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.327
AS - Asia 850
EU - Europa 587
SA - Sud America 214
Continente sconosciuto - Info sul continente non disponibili 46
AF - Africa 24
Totale 3.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.266
SG - Singapore 401
CN - Cina 176
IT - Italia 169
BR - Brasile 158
DE - Germania 87
FR - Francia 82
VN - Vietnam 72
SE - Svezia 62
CA - Canada 40
GB - Regno Unito 40
BD - Bangladesh 39
JP - Giappone 34
IE - Irlanda 30
FI - Finlandia 29
ID - Indonesia 29
AR - Argentina 23
IN - India 23
KR - Corea 23
PL - Polonia 15
UA - Ucraina 15
CO - Colombia 11
EC - Ecuador 11
HK - Hong Kong 11
RU - Federazione Russa 11
ES - Italia 9
MX - Messico 9
NL - Olanda 8
BE - Belgio 6
PK - Pakistan 6
SA - Arabia Saudita 6
AT - Austria 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
BA - Bosnia-Erzegovina 4
MA - Marocco 4
TR - Turchia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
PY - Paraguay 3
VE - Venezuela 3
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
PR - Porto Rico 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
JO - Giordania 1
LI - Liechtenstein 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 3.003
Salva come PNG Salva come JPEG
Città #
Singapore 242
Ashburn 123
San Jose 117
Chandler 97
New York 86
Los Angeles 69
Hefei 45
Buffalo 43
Beijing 41
Tokyo 33
Frankfurt am Main 29
Milan 29
Dublin 28
The Dalles 27
Ho Chi Minh City 26
Munich 23
Jakarta 22
Seoul 22
Council Bluffs 21
Lauterbourg 20
Rome 20
Toronto 18
Paris 17
Santa Clara 16
Boardman 15
Chicago 15
Hanoi 13
Helsinki 13
Marseille 13
Brooklyn 12
Dallas 12
Hong Kong 11
Kent 11
Nuremberg 11
São Paulo 11
Warsaw 11
Boston 10
Wilmington 10
Atlanta 9
Houston 9
Bogotá 8
Montreal 8
Pune 8
Turku 8
Jacksonville 7
Memphis 7
North Bergen 7
Princeton 7
Seattle 7
Brussels 6
Charlotte 6
London 6
Orem 6
Bari 5
Chennai 5
Curitiba 5
Fairfield 5
Lappeenranta 5
Naples 5
Phoenix 5
Poplar 5
Portsmouth 5
Quito 5
Rio de Janeiro 5
San Francisco 5
Appignano 4
Baghdad 4
Brasília 4
Dhaka 4
Guarulhos 4
Las Vegas 4
Madrid 4
Moscow 4
Redwood City 4
San Diego 4
Sarajevo 4
Stockholm 4
Turin 4
Albiate 3
Ann Arbor 3
Belo Horizonte 3
Biên Hòa 3
Buenos Aires 3
Cairo 3
Campinas 3
Caxias do Sul 3
Chelsea 3
Düsseldorf 3
Figino 3
Florence 3
Harrison 3
Hyderabad 3
Johannesburg 3
Lahore 3
Manaus 3
Miami 3
Monte Argentario 3
Mumbai 3
Ottawa 3
Ribeirão Preto 3
Totale 1.669
Salva come PNG Salva come JPEG
Nome #
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 347
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 271
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 165
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 135
Effect of moderate and heavy alcohol consumption on intestinal transit time 134
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. 128
Microbiota Composition in Diverticular Disease: Implications for Therapy 123
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 120
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 116
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 111
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 108
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 104
Microbiota Composition in Diverticular Disease: Implications for Therapy 104
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease 104
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 101
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 101
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 93
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 90
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 87
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? 84
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 80
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis 78
Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 76
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease 62
Response to Jackson et al 61
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 58
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 7
Totale 3.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202276 0 0 0 0 1 1 2 4 3 18 23 24
2022/2023237 27 27 11 40 13 25 16 26 19 10 16 7
2023/2024235 9 43 23 17 8 31 21 4 18 22 28 11
2024/2025557 13 10 45 20 46 13 21 19 46 77 139 108
2025/20261.310 201 54 108 194 211 56 175 48 69 105 45 44
2026/2027533 291 225 17 0 0 0 0 0 0 0 0 0
Totale 3.048